These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21932441)

  • 41. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel multidimensional protein identification technology approach combining protein size exclusion prefractionation, peptide zwitterion-ion hydrophilic interaction chromatography, and nano-ultraperformance RP chromatography/nESI-MS2 for the in-depth analysis of the serum proteome and phosphoproteome: application to clinical sera derived from humans with benign prostate hyperplasia.
    Garbis SD; Roumeliotis TI; Tyritzis SI; Zorpas KM; Pavlakis K; Constantinides CA
    Anal Chem; 2011 Feb; 83(3):708-18. PubMed ID: 21174401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
    Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
    Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer.
    Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Zhang X; Akada J; Oka M; Nakamura K
    Oncol Rep; 2012 Nov; 28(5):1845-50. PubMed ID: 22940724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
    Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
    Chou CY; Chang CT; Chen CJ
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomics analysis of bodily fluids in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics.
    Kondo T
    Expert Rev Proteomics; 2014 Feb; 11(1):9-12. PubMed ID: 24351084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites.
    Huang X; Zhou J; Tang R; Han S; Zhou X
    Int J Gynecol Cancer; 2018 Feb; 28(2):355-362. PubMed ID: 29240604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.
    Ludvigsen M; Hamilton-Dutoit SJ; d'Amore F; Honoré B
    Proteomics Clin Appl; 2015 Feb; 9(1-2):72-85. PubMed ID: 25504580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploration of the platelet proteome in patients with early-stage cancer.
    Sabrkhany S; Kuijpers MJE; Knol JC; Olde Damink SWM; Dingemans AC; Verheul HM; Piersma SR; Pham TV; Griffioen AW; Oude Egbrink MGA; Jimenez CR
    J Proteomics; 2018 Apr; 177():65-74. PubMed ID: 29432918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods and applications of serological proteome analysis.
    Fulton KM; Martin SS; Wolfraim L; Twine SM
    Methods Mol Biol; 2013; 1061():97-112. PubMed ID: 23963932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pancreatic cancer proteome - recent advances and future promise.
    Aspinall-O'Dea M; Costello E
    Proteomics Clin Appl; 2007 Sep; 1(9):1066-79. PubMed ID: 21136758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteome-based biomarkers in pancreatic cancer.
    Sun C; Rosendahl AH; Ansari D; Andersson R
    World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PeptideAtlas of the Domestic Laying Hen.
    McCord J; Sun Z; Deutsch EW; Moritz RL; Muddiman DC
    J Proteome Res; 2017 Mar; 16(3):1352-1363. PubMed ID: 28166638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-depth proteomic analyses of direct expressed prostatic secretions.
    Drake RR; Elschenbroich S; Lopez-Perez O; Kim Y; Ignatchenko V; Ignatchenko A; Nyalwidhe JO; Basu G; Wilkins CE; Gjurich B; Lance RS; Semmes OJ; Medin JA; Kislinger T
    J Proteome Res; 2010 May; 9(5):2109-16. PubMed ID: 20334419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
    Badr HA; Alsadek DM; Darwish AA; Elsayed AI; Bekmanov BO; Khussainova EM; Zhang X; Cho WC; Djansugurova LB; Li CZ
    Expert Rev Proteomics; 2014 Apr; 11(2):227-36. PubMed ID: 24611567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor interstitial fluid: proteomic determination as a possible source of biomarkers.
    Baronzio G; Parmar G; Baronzio M; Kiselevsky M
    Cancer Genomics Proteomics; 2014; 11(5):225-37. PubMed ID: 25331795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deciphering the complexity of the cancer proteome for diagnostic applications.
    Hanash S; Taguchi A; Wang H; Ostrin EJ
    Expert Rev Mol Diagn; 2016; 16(4):399-405. PubMed ID: 26694525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
    Ansari D; Sambergs F; Johansson L; Andersson R
    Expert Rev Proteomics; 2017 Jun; 14(6):469-471. PubMed ID: 28388239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.